Bristol Will Buy Diabetes Drug Maker

Bristol-Myers Squibb said it will buy diabetes drug maker Amylin in a $7 billion deal that will intensify the competition to treat the growing number of people afflicted with the disease.

ASK NEWS:
  • Type 2 Diabetes Global Clinical Trials Review, H1, 2014 - Sacramento Bee
    Autism advocates plea: don’t go home without passing treatment ... - Raleigh News & Observer
    07/15/2014 - 4:12 am | View Link
  • More
BING NEWS:
  • AstraZeneca to buy out Bristol stake in diabetes JV for up to $4.1 bn
    has agreed to buy Bristol-Myers Squibb Co.’s stake in the diabetes ... Last week the venture received a boost when an advisory panel to the US Food and Drug Administration endorsed its new diabetes pill dapagliflozin. Reuters
    12/19/2013 - 5:12 pm | View Link
  • AstraZeneca to buy Bristol stake in diabetes venture for up to $4.1 bln
    Speculation that such a deal might be on the cards was fuelled last month after Bristol decided to exit diabetes drug research. The Bristol-AstraZeneca diabetes joint venture includes the oral medicines Onglyza, Kombiglyze and Forxiga, as well as the ...
    12/18/2013 - 6:58 pm | View Link
  • EU OKs Bristol-Myers, AstraZeneca diabetes drug
    (AP) -- Drugmaker Bristol-Myers Squibb Co. said Monday that its new diabetes drug, Onglyza, has been approved for sale in the European Union's 27 countries. (AP) — Drug maker Bristol-Myers Squibb Co. says it agreed to buy diabetes drug maker Amylin ...
    11/14/2012 - 6:58 am | View Link
  • Bristol-Myers, AZ aim for diabetes glory with Amylin buy
    Now that Bristol-Myers Squibb ($BMY) and AstraZeneca ($AZN) have teamed up to buy Amylin Pharmaceuticals ($AMLN), the ... AstraZeneca will pay Bristol-Myers $3.4 billion for beefing up their current diabetes-drug alliance. Obviously, Astra and Bristol ...
    07/2/2012 - 4:24 am | View Link
  • Bristol-Myers To Buy Diabetes Drug Maker For $5B
    NEW YORK (AP) — Bristol-Myers Squibb Co. agreed to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash, heating up the competition among drugmakers to develop diabetes treatments. After the deal is complete, Bristol-Myers will ...
    07/1/2012 - 1:00 pm | View Link
  • More
BING SEARCH:
  • SGLT-2 Drugs = A New Class of Medication, Since Diabetes ...
    Sometimes, diabetes science confuses me. Let’s take the news of an emerging class of diabetes drugs (type 2-focused) that apparently do something we’ve ...
    07/23/2014 - 8:12 pm | View Website
  • Reverse Diabetes
    July 22, 2014 . The diabetes breakthrough you’re about to discover on this page is twice as effective as the leading type 2 drug and has been used successfully by ...
    07/23/2014 - 6:54 pm | View Website
  • Generic Drugs (Show All) :: Diabetes Self-Management
    People with diabetes often take multiple drugs, including blood-glucose-lowering pills or insulin, blood-pressure-lowering pills, and cholesterol-lowering ...
    07/23/2014 - 3:26 pm | View Website
  • Where Can I Get Help Paying for Diabetic Medications? | eHow
    Where Can I Get Help Paying for Diabetic Medications?. Drug companies have recognized that some of their medications are cost prohibitive for many people. In an ...
    07/23/2014 - 12:13 pm | View Website
  • Bristol-Myers Squibb: Press Releases
    Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over ...
    07/23/2014 - 12:24 am | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News